Bio-Techne Corporation TECH | NASDAQ

$73.17 $1.78 | 2.49%

After Hours
$73.18 $0.01 | 0.01%

Next Earnings: Jan 30, 2025

Company Overview:

Market Cap: $11.63B
PE Ratio: 77.02
52-Week Range: $61.16 - $85.57
Dividend Yield (FWD): 0.44% ($0.32)

10 Year Performance Metrics:

Total Return (with DRIP): 234.83% (12.84% / yr)
Total Return (no DRIP): 225.39% (12.52% / yr)
Share Price: 211.76%
Dividend Increase: 0.00%
TECH 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

TECH Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
TECH Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Share Price
TECH Price CAGR:1Y: -3.55%2Y: -4.97%5Y: 5.68%10Y: 12.05%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

TECH Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - TECH
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - TECH
14-Day FREE Trial Get Full Access Now!

TECH Earnings, Revenue, Cash & Debt, Shares Outstaning:

TECH - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
TECH - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
TECH - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
TECH - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
TECH - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
TECH - Cash & Debt
14-Day FREE Trial Get Full Access Now!
TECH - Revenue
14-Day FREE Trial Get Full Access Now!
TECH Revenue CAGR:1Y: 4.52%2Y: 3.61%5Y: 9.58%10Y: 10.31%
TECH - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
TECH EPS CAGR:1Y: -32.26%2Y: -38.21%5Y: 18.02%10Y: 2.76%
TECH - Net Income
14-Day FREE Trial Get Full Access Now!
TECH Net Income CAGR:1Y: -34.11%2Y: -38.75%5Y: 18.47%10Y: 3.46%
TECH - EBITDA
14-Day FREE Trial Get Full Access Now!
TECH EBITDA CAGR:1Y: -12.48%2Y: -5.64%5Y: 17.25%10Y: 7.69%
TECH - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
TECH Free Cash Flow CAGR:1Y: 19.49%2Y: 8.45%5Y: 12.76%10Y: 5.91%
TECH - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
TECH Free Cash Flow / Share CAGR:1Y: 19.19%2Y: 7.90%5Y: 11.84%10Y: 5.19%
TECH - Gross Profit
14-Day FREE Trial Get Full Access Now!
TECH Gross Profit CAGR:1Y: -1.17%2Y: 0.95%5Y: 9.10%10Y: 9.62%
TECH - Expenses
14-Day FREE Trial Get Full Access Now!
TECH Expenses CAGR:1Y: -32.52%2Y: -2.03%5Y: -2.71%10Y: 6.46%
TECH - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
TECH Shares Outstanding CAGR:1Y: -0.51%2Y: -0.33%5Y: 0.52%10Y: 0.81%
TECH - Share Buybacks
14-Day FREE Trial Get Full Access Now!
TECH Share Buybacks CAGR:1Y: -100.00%2Y: -100.00%5Y: N/A10Y: N/A
TECH - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
TECH Stock-Based Comp CAGR:1Y: 0.90%2Y: -16.08%5Y: 4.01%10Y: 22.29%
TECH - Dividends
14-Day FREE Trial Get Full Access Now!
TECH Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
TECH - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
TECH Revenue CAGR:1Y: 4.52%2Y: 3.61%5Y: 9.58%10Y: 10.31%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

TECH - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TECH Actual Revenue CAGR:1Y: 4.52%2Y: 3.61%5Y: 9.58%10Y: 10.31%
TECH - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TECH Actual EPS CAGR:1Y: -32.26%2Y: -38.21%5Y: 18.02%10Y: 2.76%
TECH - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TECH Actual Net Income CAGR:1Y: -34.11%2Y: -38.75%5Y: 18.47%10Y: 3.46%
TECH - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
TECH Actual EBITDA CAGR:1Y: -12.48%2Y: -5.64%5Y: 17.25%10Y: 7.69%

Ratios, Profit Margins & Return on Capital:

TECH - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
TECH Net Profit Margin CAGR:1Y: -36.94%2Y: -40.87%5Y: 8.11%10Y: -6.21%
TECH - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
TECH Gross Profit Margin CAGR:1Y: -5.44%2Y: -2.56%5Y: -0.43%10Y: -0.63%
TECH - Price to Earnings
14-Day FREE Trial Get Full Access Now!
TECH - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
TECH - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
TECH - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

TECH Dividends Info:

Annual Dividend: $0.32
Forward Yield: 0.44%
Ex-Dividend Date: 2024-11-08
Lifetime Dividens / Share: $4.95

TECH Dividend History: Dates, Payments & Yield list

Below is a schedule of all TECH dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
11/08/202411/22/2024$0.0800.42%0.42%$75.96
08/19/202408/30/2024$0.0800.43%0.43%$74.99
05/10/202405/24/2024$0.0800.4%0.4%$80.91
02/09/202402/26/2024$0.0800.47%0.47%$67.95
11/09/202311/24/2023$0.0800.56%0.56%$56.86
08/17/202309/01/2023$0.0800.4%0.4%$80.24
05/12/202305/26/2023$0.0800.39%0.39%$81.30
02/10/202302/27/2023$0.0800.42%0.42%$76.29
11/10/202211/28/2022$0.0800.38%0.38%$84.27
08/12/202208/29/2022$0.0800.34%0.34%$94.91
05/13/202205/27/2022$0.0800.35%0.35%$91.94
02/10/202202/25/2022$0.0800.3%0.3%$105.72
11/10/202111/26/2021$0.0800.25%0.25%$125.92
08/13/202108/27/2021$0.0800.27%0.27%$116.74
05/14/202105/28/2021$0.0800.32%0.32%$100.34
02/11/202102/26/2021$0.0800.32%0.32%$98.75
11/13/202011/27/2020$0.0800.42%0.42%$75.71
08/17/202008/28/2020$0.0800.49%0.49%$65.68
05/08/202005/22/2020$0.0800.47%0.47%$67.63
02/13/202002/28/2020$0.0800.62%0.62%$51.41
11/07/201911/22/2019$0.0800.63%0.63%$50.74
08/15/201908/30/2019$0.0800.66%0.66%$48.21
05/09/201905/24/2019$0.0800.63%0.63%$50.47
02/14/201903/01/2019$0.0800.68%0.68%$47.14
11/08/201811/23/2018$0.0800.74%0.74%$43.22
08/16/201808/31/2018$0.0800.71%0.71%$44.93
05/11/201805/25/2018$0.0800.85%0.84%$37.87
02/15/201803/02/2018$0.0800.9%0.9%$35.38
11/09/201711/24/2017$0.0801.03%1.03%$31.17
08/16/201709/01/2017$0.0801.08%1.08%$29.58
05/17/201706/02/2017$0.0801.17%1.17%$27.40
02/15/201703/03/2017$0.0801.22%1.22%$26.30
11/09/201611/28/2016$0.0801.23%1.23%$25.96
08/25/201609/12/2016$0.0801.22%1.22%$26.27
05/11/201605/27/2016$0.0801.26%1.26%$25.32
02/10/201602/26/2016$0.0801.51%1.51%$21.23
11/10/201511/27/2015$0.0801.41%1.41%$22.63
08/13/201508/28/2015$0.0801.21%1.21%$26.50
05/13/201505/29/2015$0.0801.28%1.29%$24.72
02/11/201502/27/2015$0.0801.38%1.4%$22.84
11/06/201411/24/2014$0.0801.37%1.4%$22.79
08/19/201408/29/2014$0.0781.29%1.29%$24.06
05/07/201405/23/2014$0.0781.34%1.36%$22.87
02/12/201402/28/2014$0.0781.39%1.41%$21.92
11/07/201311/25/2013$0.0781.42%1.45%$21.35
08/14/201308/30/2013$0.0751.56%1.56%$19.25
05/08/201305/24/2013$0.0751.77%1.8%$16.68
02/13/201303/01/2013$0.0751.7%1.76%$17.09
11/01/201211/19/2012$0.0751.64%1.72%$17.43
08/08/201208/24/2012$0.0701.63%1.63%$17.14
05/09/201205/25/2012$0.0701.61%1.63%$17.20
02/08/201202/24/2012$0.0701.63%1.66%$16.89
11/03/201111/21/2011$0.0701.57%1.61%$17.40
08/10/201108/26/2011$0.0681.57%1.57%$17.23
05/11/201105/27/2011$0.0681.35%1.36%$19.79
02/09/201102/28/2011$0.0681.56%1.59%$16.95
11/04/201011/22/2010$0.0681.74%1.78%$15.13
08/12/201008/31/2010$0.0651.72%1.72%$15.09
05/12/201005/28/2010$0.0651.62%1.64%$15.88
02/10/201002/26/2010$0.0651.69%1.72%$15.12
11/05/200911/23/2009$0.0651.57%1.61%$16.11
08/13/200908/31/2009$0.0631.64%1.64%$15.27
05/06/200905/22/2009$0.0631.29%1.72%$14.52
02/11/200902/27/2009$0.0630.91%1.83%$13.68
10/30/200811/17/2008$0.0630.37%1.47%$16.98

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for TECH

Based on past 10-year performance, here are TECH growth metrics:

Share price CAGR of +12.04%
Dividend CAGR of +0%
Using TECH CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

TECH
Current Price$73.17
Start Shares136.67
Start Value$10,000
 
After 10 years:
Final Share Count140.50
Dividends Payment$0.08
Annual Dividends$45
Yield on cost0.45%
Share Price$203.60
Total Dividends$444
Final Value$28,605

Estimated Future Value + Dividends - TECH

NOTE: Above numbers are our estimate based on TECH's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Bio-Techne Corporation (TECH) had its IPO on 1989-02-09, and is trader on NASDAQ stock exchange.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

TECH website: https://www.bio-techne.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial